title: Outpatient therapeutic 131I for thyroid cancer.
abstract: OBJECTIVE
  We retrospectively analyzed the safety, cost effectiveness, and patient acceptance of outpatient high-dose 131I treatment for thyroid cancer at our hospital since 1997, when the Nuclear Regulatory Commission began allowing high-dose outpatient therapy with radioiodine.
  
  
  METHODS
  Forty-eight patients were treated as outpatients because their living conditions were acceptable and they were willing to comply with radiation safety guidelines. The homes of 3 patients were surveyed for contamination. The cost of outpatient treatment was compared with the cost of inpatient treatment. Patient acceptance was assessed by patient satisfaction surveys performed at the time of the posttherapy scan.
  
  
  RESULTS
  No levels of contamination above regulatory levels were found in patients' homes. The cost of outpatient treatment was favorable. All surveyed patients were pleased with the procedure.
  
  
  CONCLUSIONS
  If state and federal guidelines for releasing patients are followed, and if patients' living conditions are adequately assessed, outpatient treatment with high-dose 131I is safe and cost effective and improves patient satisfaction.
authors.affiliation: Department of Radiology, Medical University of South Carolina, Charleston, South Carolina 29425, USA.
authors.forename: Beata
authors.initials: B
authors.lastname: Panzegrau
authors.forename: Leonie
authors.initials: L
authors.lastname: Gordon
authors.forename: Glen H
authors.initials: GH
authors.lastname: Goudy
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000553:Ambulatory Care / Q000191:economics* / Q000706:statistics & numerical data*; D001822:Body Burden; D003258:Consumer Behavior / Q000706:statistics & numerical data*; D004781:Environmental Exposure / Q000032:analysis*; D006801:Humans; D007457:Iodine Radioisotopes / Q000032:analysis / Q000191:economics* / Q000627:therapeutic use*; D008875:Middle Aged; D011835:Radiation Protection / Q000379:methods; D012062:Relative Biological Effectiveness; D012189:Retrospective Studies; D018570:Risk Assessment / Q000379:methods; D012307:Risk Factors; D013022:South Carolina / Q000453:epidemiology; D013964:Thyroid Neoplasms / Q000191:economics* / Q000453:epidemiology / Q000532:radiotherapy*
chemical_list: D007457:Iodine Radioisotopes